MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Fatigue in patients with progressive supranuclear palsy

    JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate prevalence and clinical impact of fatigue in the patients with progressive supranuclear palsy Background: Fatigue is a common and disabling non-motor symptom…
  • MDS Virtual Congress 2021

    Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders

    P. Zhang, J. Chen, T. Cai, Y. Zhang (Guangzhou, China)

    Objective: We employed Quantitative susceptibility mapping (QSM) to assess iron deposition in a larger sample size and explore whether combining QSM and NfL can improve…
  • MDS Virtual Congress 2021

    Onset of complications in patients with Parkinson disease in Brazilian Amazon: cohort study.

    D. Moura, A. Escudeiro, A. Silva, B. Koshimoto, R. Feio, B. Lobato (Belém, Brazil)

    Objective: To assess the onset of complications in patients with Parkinson’s disease (PD) in early stage, in a Brazilian Amazon city. Background: PD is a…
  • MDS Virtual Congress 2021

    Early Observations of Using a Chronically Implanted INS that can Sense Local Field Potentials in Movement Disorder Patients

    T. Theys, M. Case, A. van Hoylandt, A. Singer, K. Bhatia (Leuven, Belgium)

    Objective: The objective of this study is to report early findings from movement disorder and epilepsy patients that have been implanted with an INS device…
  • MDS Virtual Congress 2021

    Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies

    K. Mathias, A. Pinto, E. Matar, J. Phillips, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To characterize and differentiate gait deficits early on in individuals with DLB and PD. Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition

    L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate whether subjective cognitive complaints assessed by the Non-Motor Symptoms Scale (NMSS) are predictive of longitudinal cognitive trajectories in cognitively intact people with…
  • MDS Virtual Congress 2021

    Initial longitudinal analyses of objectively assessed cognitive functional abilities in a cohort with Parkinson’s disease

    S. Holden, A. Fought, K. Olson, N. Lopez-Esquibel, T. Carlisle, L. Medina (Aurora, USA)

    Objective: Detect the earliest changes in cognitively demanding activities of daily living in Parkinson's disease (PD) and determine their relationship with changes in global cognition…
  • MDS Virtual Congress 2021

    Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

    D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

    Objective: To consolidate the current literature pertaining to cognitive subtypes derived using data-driven methods in Parkinson’s Disease (PD). Background: Recent application of the Mild Cognitive…
  • MDS Virtual Congress 2021

    The Global Parkinson’s Genetics Program (GP2) – a year’s progress

    C. Blauwendraat, A. Noyce, A. Reimer, B. Casey, E. Riley, B. Fiske, M. Rizig, J. Hardy, T. Foroud, K. Murphy, N. Wood, C. Wegel, A. Brice, S. Fox, P. Heutink, R. Krueger, N. Williams, T. Gasser, K. Mok, M. Sharma, K. Marek, T. Sherer, N. Mata, M. Nalls, E. Valente, H. Morris, C. Klein, A. Singleton, T. He-Global-Parkinson’S-Genetics-Program-(gp2) (Bethesda, USA)

    Objective: The Global Parkinson’s Genetics Program (GP2, http://gp2.org/) aims to dramatically expand the current understanding of the genetic architecture of Parkinson’s disease (PD) and to…
  • MDS Virtual Congress 2021

    Methylation status of SNCA gene in multiple system atrophy and Parkinson’s disease

    E. Iakovenko, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)

    Objective: Parkinson’s disease (PD) and multiple system atrophy (MSA) are classical synucleinopathies caused by misfolding of alpha-synuclein protein. Clinical picture of PD and MSA in…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley